Global Digital Biomarker Market to Touch USD 46,131.4 Million till 2030 by Growing with a CAGR of 41.22% Between 2020 and 2030; Increasing Application of Digital Biomarkers in Neurological Disorders

Research Nester published a report titled “Digital Biomarker Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global digital biomarker market in terms of market segmentation by system component, by therapeutic area, by application, development status and by end user. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

As per the data provided by the Alzheimer’s Association, by the year 2050, around 12.7 Million people aged 65 and older are estimated to have Alzheimer’s dementia.

Alzheimer’s disease represents a rapidly growing burden in the healthcare ecosystem. Although digital biomarkers are slowly finding application in various health conditions such as high blood pressure and sleep apnea, they are presently highly preferred for tracking neurodegenerative disorders. Several organizations are focused on developing digital platforms to remotely collect data from smartphones and wearable devices to track subtle changes in behavior, which will further help detect the disease. Moreover, the Biomarkers for Alzheimer’s Disease Summit, a digital forum, is dedicated to solving the problem of developing clinically validated markers for the early detection of Alzheimer’s. The global digital biomarker market accounted for USD 1,043.3 Million in 2019 and is estimated to grow at a CAGR of 41.22% during the forecast period, i.e., 2020-2030. The market is further expected to reach USD 46,131.4 Million by the end of 2030.

Access PDF to Get More Insights and Information @

The global digital biomarker market is segmented by application into wellness, disease diagnosis, personalized medication and drug discovery and development. Among these segments, the drug discovery and development estimated to grow with the highest CAGR of around 42.13% and is estimated to be the leading revenue generating segment by attaining a value of USD 16732.40 Million by the end of 2030.

Geographically, the global digital biomarker market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, out of which, the market in the North America market is projected to grow with a CAGR of 40.13% during the forecast period. Increasing burden of chronic diseases in the region, followed by the rise in smartphone usage are some of the major factors expected to contribute to the market growth.

However, the fact that all the healthcare information cannot be identified, captured, and used, is anticipated to pose as a major risk to the growth of the market. Additionally, lack of interoperability standards and poorly implemented regulations can hinder the seamless exchange of health data, which is further expected to act as a barrier to the growth of global digital biomarker market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global digital biomarker market which includes company profiling of ActiGraph LLC, Akili Interactive Labs, Inc., AliveCor, Inc., Altoida, Inc., Biogen Inc., ConnectedLife Health Pte Ltd, Cambridge Cognition Ltd, Evidation Health, Inc., Fitbit, Inc., Happify, Inc., Human API, GlaxoSmithKline plc, Huma, IXICO plc, Kinsa Inc., Koneksa, Medical Care Corporation, Mindstrong Health, Koninklijke Philips N.V., Neurotrack Technologies, Inc., Novartis AG, ResMed, F. Hoffmann-La Roche Ltd, Winterlight Labs, Verily Life Sciences LLC, and others.

The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “Digital Biomarker Market: Global Demand Analysis & Opportunity Outlook 2030”, analyses the overall global digital biomarker industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global digital biomarker market in the near future.    

Access PDF to Get More Insights and Information @ 

About Research Nester:

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel


U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

Leave a Reply